Status:
COMPLETED
Observational Study in Patients With HIV Infection Type 1 After Switching to a Viramune®-Containing Therapy Regimen
Lead Sponsor:
Boehringer Ingelheim
Conditions:
HIV Infections
Eligibility:
All Genders
18+ years
Brief Summary
Observational study to collect data on maintaining anti-retroviral activity (quantitative HIV RNA determination) and immunological activity (CD4 cells) despite switching from protease inhibitor to non...
Eligibility Criteria
Inclusion
- Adult male or female patients with HIV type 1 infection
Exclusion
- Counter-indications according to summary of product characteristics (SPC) for Viramune tablets
- No persons under 18
- Pregnancy and breast-feeding
- Use of oral contraceptives
- Use of drugs affecting CYP450 3A metabolism
Key Trial Info
Start Date :
December 1 1999
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT02191332
Start Date
December 1 1999
Last Update
July 16 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.